Folger Nolan Fleming Douglas Capital Management, Inc Abb Vie Inc. Transaction History
Folger Nolan Fleming Douglas Capital Management, Inc
- $889 Million
- Q2 2024
A detailed history of Folger Nolan Fleming Douglas Capital Management, Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Folger Nolan Fleming Douglas Capital Management, Inc holds 14,852 shares of ABBV stock, worth $2.87 Million. This represents 0.29% of its overall portfolio holdings.
Number of Shares
14,852
Previous 18,078
17.84%
Holding current value
$2.87 Million
Previous $3.29 Million
22.63%
% of portfolio
0.29%
Previous 0.37%
Shares
29 transactions
Others Institutions Holding ABBV
# of Institutions
3,699Shares Held
1.27BCall Options Held
13MPut Options Held
9.79M-
Vanguard Group Inc Valley Forge, PA171MShares$33 Billion0.57% of portfolio
-
Black Rock Inc. New York, NY136MShares$26.4 Billion0.54% of portfolio
-
State Street Corp Boston, MA77.8MShares$15.1 Billion0.59% of portfolio
-
Jpmorgan Chase & CO New York, NY53.6MShares$10.4 Billion0.81% of portfolio
-
Capital International Investors Los Angeles, CA38.6MShares$7.47 Billion1.4% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $342B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...